Last updated on 2022-05-26

Journal of Clinical Oncology
Research Hotspot & Journal Scope - first-line

Homepage · Submit Manuscript · Wikipedia

Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.4_SUPPL.371

Subsequent anticancer medication following first-line lenvatinib: A posthoc responder analysis from the phase 3 REFLECT study in unresectable hepatocellular carcinoma.

Angel Alsina · Masatoshi Kudo · Arndt Vogel · Ann-Lii Cheng · Won Young Tak · Baek-Yeol Ryoo · T. R. Jeffry Evans · Carlos López-López · Bruno Daniele · Soamnauth Misir · Min Ren · Namiki Izumi · Shukui Qin · Richard S. Finn ·

Medicine
PDF

Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.7_SUPPL.388

NKTR-214 + nivolumab in first-line advanced/metastatic urothelial carcinoma (mUC): Updated results from PIVOT-02.

Arlene Odelia Siefker-Radtke · Mayer Fishman · Arjun Vasant Balar · Giovanni Grignani · Adi Diab · Jianjun Gao · Mary Tagliaferri · Alison L. Hannah · Erin E. Karski · Jonathan Zalevsky · Ute Hoch · Ahsan Naqi Rizwan · Mehmet Asim Bilen ·

Medicine
PDF

Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.7_SUPPL.584

First-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Preliminary results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).

Shaan Dudani · Jeffrey Graham · Connor Wells · Sumanta K. Pal · Nazli Dizman · Frede Donskov · Georg A. Bjarnason · Aaron Richard Hansen · Marco Adelmo James Iafolla · Ulka N. Vaishampayan · Camillo Porta · Benoit Beuselinck · Flora Yan · Lori Wood · Elizabeth Chien Hern Liow · Christian Kollmannsberger · Takeshi Yuasa · Chiyuan A Zhang · Toni K. Choueiri · Daniel Yick Chin Heng ·

Medicine
PDF

Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.7_SUPPL.363

Economic burden of select adverse events (AEs) in patients (Pts) with advanced urothelial cancer (aUC) treated with first-line (1L) systemic therapy.

Petros Grivas · François Laliberté · Yunes Doleh · Cristi O’Connor · Mei Sheng Duh · Rahul Shenolikar ·

Medicine
PDF

Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.7_SUPPL.555

Axitinib versus sunitinib as first-line therapies for metastatic renal cell carcinoma: A multicenter retrospective analysis.

Shingo Hatakeyama · Toshiaki Tanaka · Yoshinori Ikehata · Naoki Fujita · Naoya Masumori · Hiroshi Kitamura · Takahiro Yoneyama · Yasuhiro Hashimoto · Chikara Ohyama ·

Medicine
PDF

Explore More Sentence Examples

Highly Related Keywords from first-line

First Line Nurse First Line Intervention First Line Therapies Undergoing First Line First Line Regimen First Line Art First Line Biologic First Line Sorafenib First Line Antiepileptic First Line Approach First Line Management First Line Combination First Line Imaging First Line Afatinib First Line Vasoactive First Line Epidermal First Line Biological First Line Egfr Tki First Line Panitumumab First Line Erlotinib First Line Haart First Line Advanced First Line Ribociclib First Line Targeted First Line Helicobacter First Line Everolimus Plus First Line First Line Drugs First Line Cetuximab First Line Antibiotics First Line Treatment First Line Nab Paclitaxel First Line First Line Methotrexate First Line Folfox Failing First Line First Line Docetaxel First Line Anti Tuberculosis First Line Antiretroviral First Line Setting First Line Metastatic First Line Bevacizumab Standard First Line First Line Treatments First Line Regimens First Line Sunitinib First Line Gefitinib First Line Folfiri First Line Durvalumab First Line Egfr As First Line First Line Investigation First Line Chemotherapy First Line Therapy First Line Tyrosine Initiating First Line First Line Pembrolizumab First Line Systemic First Line Tuberculosis First Line Antituberculosis First Line Endocrine First Line Anti Tb First Line Induction First Line Pemetrexed First Line Crizotinib Versus First Line First Line Maintenance First Line Atezolizumab First Line Daratumumab First Line Pazopanib Receiving First Line First Line Drug Avelumab First Line First Line Immunotherapy First Line Osimertinib First Line Medical Beyond First Line First Line Follicular First Line Immune First Line Egfr Tkis First Line Antidiabetic First Line Nivolumab First Line Ibrutinib First Line Palliative First Line Antimicrobials First Line Surgery Effective First Line First Line Abiraterone First Line Folfirinox First Line Non Small First Line Strategy First Line Pd 1 Pd L1 First Line Chemoimmunotherapy First Line Gemcitabine Starting First Line First Line Modality

Research Hotspot

Journal of Clinical Oncology

Research Hotspot

Journal Scope

Journal of Clinical Oncology

Journal Scope

cancer patients cell metastatic advanced phase trial carcinoma breast therapy lung analysis treatment clinical prostate outcomes tumor treated chemotherapy II survival care randomized colorectal response non-small tumors pts inhibitors renal efficacy immune versus combination Phase checkpoint stage pancreatic oncology solid DNA NSCLC neoadjuvant Cancer radiotherapy results expression receptor adenocarcinoma Results experience inhibitor squamous cohort first-line head III cancers multicenter Association safety gastric patient high-risk risk melanoma Clinical circulating urothelial neck disease progression population retrospective impact adjuvant leukemia ovarian lymphoma factors prognostic prognosis review nivolumab cells associated hepatocellular androgen role trials PD-L1 burden repair bladder patterns diagnosis data women status elderly

Research Scope

Journal of Clinical Oncology

Research Scope

cancer patients cell metastatic advanced phase trial carcinoma breast therapy lung analysis treatment clinical prostate outcomes tumor treated chemotherapy II

Journal of Clinical Oncology Related Journals

Angiogenesis Cancer Research Liver Cancer Journal of the National Comprehensive Cancer Network : JNCCN Cancer Treatment Reviews Cancer immunology research Leukemia Blood Cancer Journal Oncogene Biochimica et Biophysica Acta - Reviews on Cancer Cancer Letters European Journal of Cancer Gastric Cancer Therapeutic Advances in Medical Oncology Molecular Oncology Cancer and Metastasis Reviews Cell Death and Disease Oncogenesis Nature Reviews Clinical Oncology Nature Reviews Cancer OncoImmunology International Journal of Radiation Oncology Biology Physics Critical Reviews in Oncology/Hematology Blood Reviews British Journal of Cancer Cancer Neoplasia Molecular Cancer Therapeutics Cancer Immunology, Immunotherapy Cancer Biology and Medicine Cellular Oncology Advances in Cancer Research PLoS Genetics International Journal of Cancer Translational Lung Cancer Research Oncologist Breast Cancer Research Cancer Science Oncology Research Radiotherapy and Oncology Frontiers in Oncology Endocrine-Related Cancer Lung Cancer Cancer Nanotechnology Molecular Cancer Research Gynecologic Oncology Carcinogenesis Apoptosis : an international journal on programmed cell death Cancer Gene Therapy Cancer Epidemiology Biomarkers and Prevention Prostate Cancer and Prostatic Diseases Epigenetics Cytotherapy Seminars in Oncology Molecular Therapy - Oncolytics Epigenomics Journal of immunotherapy (Hagerstown, Md. : 1997) Seminars in Radiation Oncology Annals of Surgical Oncology Targeted Oncology The Lancet Oncology Oral Oncology European Journal of Surgical Oncology Current Treatment Options in Oncology International Journal of Oncology Breast Cancer Research and Treatment Current Oncology Reports Molecular Carcinogenesis Cancer Cytopathology Cancer Research and Treatment Breast Current Opinion in HIV and AIDS Acta Oncologica Pigment Cell and Melanoma Research Cancer Biology and Therapy Open Forum Infectious Diseases Journal of Cancer Research and Clinical Oncology International Journal of Hyperthermia Expert Review of Anticancer Therapy Journal of Cancer Translational Oncology Journal of Oncology Practice Clinical Lung Cancer United European Gastroenterology Journal Investigational New Drugs Cancer Medicine Cancer Prevention Research Human Cell Genes Chromosomes and Cancer Cancer Biomarkers Oncology Reports American Journal of Translational Research OncoTargets and Therapy Current Opinion in Oncology Nitric Oxide - Biology and Chemistry Journal of Gynecologic Oncology Journal of Cancer Survivorship Journal of Mammary Gland Biology and Neoplasia Cancer Genomics and Proteomics Prostate More

Popular Journals